CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-26 | THURMAN RANDY H Director | Purchase | +5,000 | $0.43 | $2K | 5,593 |
| 2026-05-26 | HILZINGER KURT J Director | Purchase | +400,000 | $0.44 | $177K | 423,655 |
| 2025-10-03 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +53,316 | 53,316 | ||
| 2025-10-03 | Haller Julia A Director | Grant or award · Stock Option (Right to Buy) | +58,648 | 58,648 | ||
| 2025-10-03 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +90,638 | 90,638 | ||
| 2025-10-03 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +95,969 | 95,969 | ||
| 2025-10-03 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +58,648 | 58,648 | ||
| 2025-10-03 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +117,296 | 117,296 | ||
| 2025-10-01 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +286,734 | 286,734 | ||
| 2025-10-01 | Haller Julia A Director | Grant or award · Stock Option (Right to Buy) | +286,734 | 286,734 | ||
| 2025-10-01 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +286,734 | 286,734 | ||
| 2025-10-01 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +286,734 | 286,734 | ||
| 2025-10-01 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +286,734 | 286,734 | ||
| 2025-10-01 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +286,734 | 286,734 | ||
| 2025-10-01 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +286,734 | 286,734 | ||
| 2025-10-01 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +286,734 | 286,734 | ||
| 2025-07-01 | Jahr Robert Charles Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2025-05-27 | Sukhtian Ghiath M. Director | Grant or award | +4,285,714 | $1.40 | $6.0M | 13,552,359 |
| 2025-05-27 | Sukhtian Ghiath M. Director | Grant or award · Warrants (right to buy) | +8,571,428 | 8,571,428 | ||
| 2025-02-04 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +12,323 | 12,323 |
Page 2 of 8 · 142 trades